Description

This service provides state-of-the-industry insights for companion diagnostic co-development partnerships between drug companies and their diagnostic partners. Topics include drivers for companion diagnostic programs, a comparison of co-development business models, a guide for what drug companies look for in companion diagnostic partners, and an outline of the various opportunities for servicing pharmaceutical clients. Final recommendations are given for how to compete in a market that will be impacted by the changing trends of in vitro diagnostics, reimbursements, and regulatory oversights.